Wilmington Savings Fund Society’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.6K Sell
4,474
-50
-1% -$598 ﹤0.01% 855
2026
Q1
$27.1K Sell
4,524
-33
-0.7% -$248 ﹤0.01% 1004
2025
Q4
$32.7K Sell
4,557
-188
-4% -$1.49K ﹤0.01% 970
2025
Q3
$50.7K Sell
4,745
-2,916
-38% -$28.6K ﹤0.01% 890
2025
Q2
$74.2K Sell
7,661
-1,935
-20% -$20K ﹤0.01% 1118
2025
Q1
$143K Sell
9,596
-1,314
-12% -$20.2K ﹤0.01% 899
2024
Q4
$163K Buy
10,910
+1,248
+13% +$20.3K ﹤0.01% 895
2024
Q3
$185K Buy
+9,662
New +$200K ﹤0.01% 843
2022
Q1
Sell
-16,341
Closed -$497K 389
2021
Q4
$497K Sell
16,341
-1,201
-7% -$39.1K 0.02% 283
2021
Q3
$574K Sell
17,542
-1,928
-10% -$61.7K 0.02% 273
2021
Q2
$589K Buy
+19,470
New +$641K 0.02% 270

Other funds holding OGN

Wilmington Savings Fund Society's OGN Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Organon & Co (OGN) stake by 1.1% in Q2 2026, selling an estimated $598 and leaving 4,474 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #855.

Wilmington Savings Fund Society first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $589K in Q2 2021. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Wilmington Savings Fund Society held 4,474 shares of Organon & Co worth $60.6K as of Q2 2026.
  • Wilmington Savings Fund Society sold 50 Organon & Co shares in Q2 2026, an estimated $598.
  • Organon & Co made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #855 holding.
  • Wilmington Savings Fund Society first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
  • Wilmington Savings Fund Society's Organon & Co position peaked at $589K in Q2 2021.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.